Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma

被引:4
|
作者
Kondo, Satoru [1 ,2 ]
Okabe, Atsushi [2 ]
Nakagawa, Takuya [2 ,3 ]
Matsusaka, Keisuke [2 ,4 ]
Fukuyo, Masaki [2 ,5 ]
Rahmutulla, Bahityar [2 ]
Dochi, Hirotomo [1 ]
Mizokami, Harue [1 ,2 ]
Kitagawa, Yuki [1 ]
Kurokawa, Tomoya [2 ,3 ]
Mima, Masato [2 ,6 ]
Endo, Kazuhira [1 ]
Sugimoto, Hisashi [1 ]
Wakisaka, Naohiro [1 ]
Misawa, Kiyoshi [6 ]
Yoshizaki, Tomokazu [1 ]
Kaneda, Atsushi [2 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Div Otorhinolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Chiba 2600856, Japan
[3] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chiba, Chiba 2602856, Japan
[4] Chiba Univ Hosp, Dept Pathol, Chiba, Chiba 2602856, Japan
[5] Kazusa DNA Res Inst, Dept Genome Res & Dev, Kisarazu, Chiba 2920818, Japan
[6] Hamamatsu Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Hamamatsu, Shizuoka 4313192, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2023年 / 1869卷 / 02期
关键词
DERL3; DNA methylation; Epstein-Barr virus; Latent membrane protein 1; Nasopharyngeal carcinoma; EPITHELIAL-MESENCHYMAL TRANSITION; PROMOTER HYPERMETHYLATION; HISTONE MODIFICATIONS; CANCER; GENE; EXPRESSION; LATENT-MEMBRANE-PROTEIN-1; ACTIVATION; MUTATIONS;
D O I
10.1016/j.bbadis.2022.166598
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nasopharyngeal carcinoma (NPC) is Epstein-Barr virus (EBV)-associated invasive malignancy. Increasing evi-dence indicates that epigenetic abnormalities, including DNA methylation, play important roles in the devel-opment of NPC. In particular, the EBV principal oncogene, latent membrane protein 1 (LMP1), is considered a key factor in inducing aberrant DNA methylation of several tumour suppressor genes in NPC, although the mechanism remains unclear. Herein, we comprehensively analysed the methylome data of Infinium BeadArray from 51 NPC and 52 normal nasopharyngeal tissues to identify LMP1-inducible methylation genes. Using hi-erarchical clustering analysis, we classified NPC into the high-methylation, low-methylation, and normal-like subgroups. We defined high-methylation genes as those that were methylated in the high-methylation sub -group only and common methylation genes as those that were methylated in both high-and low-methylation subgroups. Subsequently, we identified 715 LMP1-inducible methylation genes by observing the methylome data of the nasopharyngeal epithelial cell line with or without LMP1 expression. Because high-methylation genes were enriched with LMP1-inducible methylation genes, we extracted 95 high-methylation genes that overlapped with the LMP1-inducible methylation genes. Among them, we identified DERL3 as the most significantly methylated gene affected by LMP1 expression. DERL3 knockdown in cell lines resulted in significantly increased cell proliferation, migration, and invasion. Lower DERL3 expression was more frequently detected in the advanced T-stage NPC than in early T-stage NPC. These results indicate that DERL3 repression by DNA methylation contributes to NPC tumour progression.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] RECK is a target of Epstein-Barr virus latent membrane protein 1
    Liu, LT
    Peng, JP
    Chang, HC
    Hung, WC
    ONCOGENE, 2003, 22 (51) : 8263 - 8270
  • [42] Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling
    Zheng, Xiao-Hui
    Li, Xi-Zhao
    Zhou, Ting
    Jiang, Cheng-Tao
    Tang, Cao-Li
    Deng, Chang-Mi
    Liao, Ying
    He, Yong-Qiao
    Wang, Tong-Min
    Jia, Wei-Hua
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (12) : 2629 - 2638
  • [43] Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein-Barr virus latent membrane protein 2
    Cai, Yiqi
    Song, Yiling
    Cen, Danwei
    Zhang, Chanqiong
    Mao, Shanshan
    Ye, Xiaoxian
    Xiong, Yirong
    Jiang, Pengfei
    Chen, Jun
    Xue, Xiangyang
    Zhang, Lifang
    Zhu, Guanbao
    ONCOLOGY LETTERS, 2018, 16 (04) : 4372 - 4378
  • [45] Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines
    Lai, Hsiao-Ching
    Hsiao, Jenn-Ren
    Chen, Chaio-Wei
    Wu, Shih-Yi
    Lee, Chien-Hsun
    Su, Ih-Jen
    Takada, Kenzo
    Chang, Yao
    VIROLOGY, 2010, 405 (02) : 464 - 473
  • [46] Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma
    Stoker, Sharon D.
    Novalic, Zlata
    Wildeman, Maarten A.
    Huitema, Alwin D. R.
    Verkuijlen, Sandra A. W. M.
    Juwana, Hedy
    Greijer, Astrid E.
    Tan, I. Bing
    Middeldorp, Jaap M.
    de Boer, Jan Paul
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1845 - 1857
  • [47] Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene
    Hao, SP
    Tsang, NM
    Chang, KP
    LARYNGOSCOPE, 2001, 111 (04) : 650 - 652
  • [48] Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma
    Noh, Min Hye
    Kim, Hye Young
    Kim, Do Hun
    Moon, Sung Ho
    Hur, Dae Young
    ANTICANCER RESEARCH, 2024, 44 (04) : 1425 - 1440
  • [49] Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
    Chan, K. C. Allen
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 598 - 603
  • [50] Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis
    Javier S. Burgos
    Medical Oncology, 2005, 22 : 113 - 121